Short-course modified regimen intrapleural alteplase and pulmozyme (DNase) in pleural infection
Pleural infection is a common clinical condition leading to hospitalisation. In the last decade, advances in pleural research have led to a paradigm shift in the treatment of complex effusion from a surgical approach to a less invasive non-surgical approach using a combination of intrapleural fibrin...
Main Authors: | M. Faisal, R. Farhan, X.K. Cheong, B.H. Ng, N. Nuratiqah, Ban Andrea YL |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Respiratory Medicine Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213007120303816 |
Similar Items
-
Low dose intrapleural alteplase and pulmozyme (DNase) in two post-surgical patients with pleural sepsis
by: M. Faisal, et al.
Published: (2020-01-01) -
Short‐course intrapleural alteplase and DNase in complex effusion with bleeding risk
by: Xiong Khee Cheong, et al.
Published: (2020-10-01) -
Intrapleural fibrinolytic therapy with alteplase in empyema thoracis in children - A prospective pilot study
by: P K Sharma, et al.
Published: (2014-01-01) -
Re‐establishing indwelling pleural catheter patency with alteplase after failure of streptokinase
by: Mohamed Faisal, et al.
Published: (2020-10-01) -
Bronchopleural communication following intrapleural doses of tPA/DNase for empyema
by: Bapti Roy, et al.
Published: (2020-10-01)